(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.61%) $83.34
(-1.16%) $1.619
(0.05%) $2 348.30
(-0.09%) $27.51
(0.11%) $923.10
(-0.10%) $0.934
(-0.06%) $11.02
(-0.14%) $0.799
(0.00%) $92.17
Live Chart Being Loaded With Signals
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments...
Stats | |
---|---|
Šios dienos apimtis | 30 154.00 |
Vidutinė apimtis | 79 420.00 |
Rinkos kapitalizacija | 19.92B |
EPS | INR0 ( 2024-02-08 ) |
Kita pelno data | ( INR0 ) 2024-05-28 |
Last Dividend | INR2.60 ( 2023-09-14 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 45.13 |
ATR14 | INR0.544 (0.08%) |
Tūris Koreliacija
Amrutanjan Health Care Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
MAHLOG.NS | 0.945 |
BAJAJHCARE.NS | 0.925 |
RHIM.NS | 0.923 |
GINNIFILA.NS | 0.921 |
SELMC.NS | 0.919 |
MCLEODRUSS.NS | 0.919 |
ONMOBILE.NS | 0.914 |
CONFIPET.NS | 0.914 |
EXCELINDUS.NS | 0.912 |
JETFREIGHT.NS | 0.91 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
CIGNITITEC.NS | -0.934 |
CERA.NS | -0.931 |
GEEKAYWIRE.NS | -0.929 |
MARSHALL.NS | -0.929 |
KPITTECH.NS | -0.922 |
CLSEL.NS | -0.922 |
KRITI.NS | -0.921 |
IONEXCHANG.NS | -0.92 |
BLUESTARCO.NS | -0.919 |
NUCLEUS.NS | -0.912 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Amrutanjan Health Care Koreliacija - Valiuta/Žaliavos
Amrutanjan Health Care Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR3.80B |
Bruto pelnas: | INR1.98B (52.05 %) |
EPS: | INR13.65 |
FY | 2022 |
Pajamos: | INR3.80B |
Bruto pelnas: | INR1.98B (52.05 %) |
EPS: | INR13.65 |
FY | 2022 |
Pajamos: | INR4.05B |
Bruto pelnas: | INR2.25B (55.49 %) |
EPS: | INR23.00 |
FY | 2021 |
Pajamos: | INR3.32B |
Bruto pelnas: | INR1.91B (57.72 %) |
EPS: | INR20.94 |
Financial Reports:
No articles found.
Amrutanjan Health Care Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR2.60 (N/A) |
INR1.000 (N/A) |
INR1.000 (N/A) |
INR0 (N/A) |
INR2.60 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.500 | 2010-02-09 |
Last Dividend | INR2.60 | 2023-09-14 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 34 | -- |
Total Paid Out | INR32.80 | -- |
Avg. Dividend % Per Year | 0.38% | -- |
Score | 2.86 | -- |
Div. Sustainability Score | 4.71 | |
Div.Growth Potential Score | 4.41 | |
Div. Directional Score | 4.56 | -- |
Year | Amount | Yield |
---|---|---|
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.950 | 0.71% |
2019 | INR2.15 | 0.75% |
2020 | INR2.35 | 0.54% |
2021 | INR4.40 | 0.88% |
2022 | INR4.60 | 0.49% |
2023 | INR3.60 | 0.50% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TATACONSUM.NS | Dividend Junior | 2023-05-19 | Annually | 26 | 0.60% | |
NIPPOBATRY.NS | Dividend Junior | 2023-09-20 | Annually | 23 | 1.06% | |
INDIANB.NS | Dividend Junior | 2023-06-12 | Annually | 18 | 1.99% | |
CIPLA.NS | Dividend Junior | 2023-07-20 | Annually | 28 | 0.41% | |
SANGHVIMOV.NS | Dividend Junior | 2023-08-04 | Sporadic | 18 | 0.41% | |
M&MFIN.NS | Dividend Junior | 2023-07-20 | Annually | 19 | 1.20% | |
GLOBUSSPR.NS | Dividend Junior | 2023-07-14 | Sporadic | 15 | 0.36% | |
ASTEC.NS | No Dividend Player | 2023-07-20 | Annually | 15 | 0.08% | |
TIPSINDLTD.NS | Dividend Junior | 2023-08-03 | Annually | 17 | 0.03% | |
PEL.NS | Dividend Junior | 2023-06-16 | Annually | 29 | 1.59% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.112 | 1.500 | 7.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.159 | 1.500 | 9.34 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 442.01 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.28 | 2.00 | 8.91 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.28 | 2.00 | 8.36 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.495 | 1.000 | 5.08 | 5.08 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.140 | 1.000 | 9.20 | 9.20 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.71 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 44.77 | 1.000 | 5.58 | 0 | [1 - 100] |
returnOnEquityTTM | 0.159 | 2.50 | 9.58 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.28 | 2.00 | 8.91 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.675 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.28 | 2.00 | 8.91 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.960 | 1.500 | 0.266 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0240 | 1.000 | -1.899 | 0 | [0.1 - 0.5] |
Total Score | 4.41 |
Amrutanjan Health Care
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons and lotions, body pain gels, and joint muscle sprays, as well as diclofenac, a non-steroidal anti-inflammatory drug. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, South East Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.